Reporter June 21 2013

Insights on glaucoma gene mutations

Glaucoma-causing mutations in the gene for myocilin reduce secretion of the protein into the aqueous humor, suggesting a new option for treatment.

Predicting cancer’s response to therapy

Researchers are developing imaging methods to predict patient outcome early in the course of chemotherapy for breast cancer – to allow clinicians to adjust therapy for patients who are not responding.

Heart illustration thumbnail

Rhythm response tied to gene variant

A genetic variant that increases risk for atrial fibrillation also impacts the response to a common therapy for the heart rhythm disorder.

Initiative to enhance operational practices

With a desire toward process improvement that will result in lasting change, and in response to ongoing financial pressures from declining reimbursements for the treatment of Medicare and Medicaid patients along with reductions to federal research funding due to the nation’s ballooning deficit, Vanderbilt University Medical Center is embarking on a comprehensive program designed to sharpen operational practices throughout the institution to better meet the economic realities facing the future of health care delivery and research.

VUSM bolstering students’ clinical experiences

Willie Melvin, M.D., assistant professor of Surgery, trains residents and more advanced medical students, so he was pleasantly surprised by first year Vanderbilt University School of Medicine students Darin Diiorio and Shaun Mansour, who had no clinical experience before arriving in his clinic last September.

Correa honored by gastroenterological society

The American Gastroentero-logical Association (AGA) has honored Pelayo Correa, M.D., with its Distinguished Achievement Award, which recognizes an individual for contributions to research that have advanced the science and practice of gastroenterology.

1 2